EcoDrugPlus

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSVPAG00000004631
Gene Symbol: MTOR
1 Cross references
214 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSVPAG00000012130
Gene Symbol: MC3R
1 Cross references
138 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSVPAG00000009923
Gene Symbol: MC4R
1 Cross references
121 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSVPAG00000012342
Gene Symbol: MTNR1A
1 Cross references
205 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSVPAG00000001905
Gene Symbol: MTNR1B
1 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSVPAG00000008471
Gene Symbol: MME
1 Cross references
234 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSVPAG00000008709
Gene Symbol: METAP2
1 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSVPAG00000002744
Gene Symbol: MAPK10
1 Cross references
147 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSVPAG00000011000
Gene Symbol: MAPK14
1 Cross references
279 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSVPAG00000009198
Gene Symbol: MAPK8
3 Cross references
294 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSVPAG00000000148
Gene Symbol: MAPK9
1 Cross references
219 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 1

Ensembl ID : ENSVPAG00000006743
Gene Symbol: MAP2K1
1 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).